National Institute For
Pharmaceutical Technology &
Education Inc
Dba Nipte
CAGE Code: 4XQ36
NCAGE Code: 4XQ36
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 808529411
Summary
National Institute For, Pharmaceutical Technology &, Education Inc, Dba Nipte is an Active Commercial Supplier with the Cage Code 4XQ36 and is tracked by Dun & Bradstreet under DUNS Number 808529411..
Address
717 Delaware St Se
Ste 482
Minneapolis MN 55414-2959
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Gtc Service Parts Co Suburban Radiology Tonerecycle Inc. Premier Electrical Corp Aerolite Inc Engel J A Inc C J's Linen Service Non Commissioned Officers Club Chars Trench Lesage Inc Carlson Marketing Group Engineered Demolition Inc H T Electronic Laboratories Inc Os/2 Express Navarre Biomedical Ltd Johnson Larry L And Associates Inc Summit Medical Systems Inc Minnesota Absorption Corp Getchell Steel Treating Co Inc Fluidyne Engineering Corp Carlson Travel Group Inc Dba Carlson
Frequently Asked Questions (FAQ) for CAGE 4XQ36
- What is CAGE Code 4XQ36?
- 4XQ36 is the unique identifier used by NATO Organizations to reference the physical entity known as National Institute For Pharmaceutical Technology & Education Inc Dba Nipte located at 717 Delaware St Se, Ste 482, Minneapolis MN 55414-2959, United States.
- Who is CAGE Code 4XQ36?
- 4XQ36 refers to National Institute For Pharmaceutical Technology & Education Inc Dba Nipte located at 717 Delaware St Se, Ste 482, Minneapolis MN 55414-2959, United States.
- Where is CAGE Code 4XQ36 Located?
- CAGE Code 4XQ36 is located in Minneapolis, MN, USA.
Contracting History for CAGE 4XQ36 Most Recent 25 Records
- 75F40122C00122
- A Model-Based Systems Engineering Approach To End-To-End Pharmaceutical Manufacturing Of Liquid
- 14 Sep 2022
- A Model-Based Systems Engineering Approach To End-To-End Pharmaceutical Manufacturing Of Liquid
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $2,701,518.97
- Department Of Health And Human Services (Hhs)
- 75F40122C00122
- A Model-Based Systems Engineering Approach To End-To-End Pharmaceutical Manufacturing Of Liquid
- 24 Jul 2023
- A Model-Based Systems Engineering Approach To End-To-End Pharmaceutical Manufacturing Of Liquid
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $4,262,209.79
- Department Of Health And Human Services (Hhs)
- 75F40122C00192
- Continuous Drug Substance Manufacturing From Biomass-Derived Building Blocks; Baa Pmqwp #356.
- 22 Sep 2022
- Continuous Drug Substance Manufacturing From Biomass-Derived Building Blocks; Baa Pmqwp #356.
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $3,000,000.00
- Department Of Health And Human Services (Hhs)
- 75F40119C10112
- Broad Agency Announcement (Baa)Contract -- Assessment Of Smoking And Vaping Risk Of Opioids And Commercial Products, And Standardization Of Methods To Asses These Properties (Pmqwp#212
- 18 Sep 2019
- Broad Agency Announcement (Baa)Contract -- Assessment Of Smoking And Vaping Risk Of Opioids And Commercial Products, And Standardization Of Methods To Asses These Properties (Pmqwp#212
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $743,717.94
- Department Of Health And Human Services (Hhs)
- 75F40119C10112
- Broad Agency Announcement (Baa)Contract -- Assessment Of Smoking And Vaping Risk Of Opioids And Commercial Products, And Standardization Of Methods To Asses These Properties (Pmqwp#212
- 10 Sep 2021
- Broad Agency Announcement (Baa)Contract -- Assessment Of Smoking And Vaping Risk Of Opioids And Commercial Products, And Standardization Of Methods To Asses These Properties (Pmqwp#212
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $760,361.01
- Department Of Health And Human Services (Hhs)
- 75F40119C10112
- Eo14042 Broad Agency Announcement (Baa)Contract -- Assessment Of Smoking And Vaping Risk Of Opioids And Commercial Products, And Standardization Of Methods To Asses These Properties (Pmqwp#212
- 25 Sep 2023
- Eo14042 Broad Agency Announcement (Baa)Contract -- Assessment Of Smoking And Vaping Risk Of Opioids And Commercial Products, And Standardization Of Methods To Asses These Properties (Pmqwp#212
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $743,717.94
- Department Of Health And Human Services (Hhs)
- 75F40119C10112
- Eo14042 Broad Agency Announcement (Baa)Contract -- Assessment Of Smoking And Vaping Risk Of Opioids And Commercial Products, And Standardization Of Methods To Asses These Properties (Pmqwp#212
- 9 Feb 2023
- Eo14042 Broad Agency Announcement (Baa)Contract -- Assessment Of Smoking And Vaping Risk Of Opioids And Commercial Products, And Standardization Of Methods To Asses These Properties (Pmqwp#212
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $760,361.01
- Department Of Health And Human Services (Hhs)
- 75F40119C10112
- Eo14042 Broad Agency Announcement (Baa)Contract -- Assessment Of Smoking And Vaping Risk Of Opioids And Commercial Products, And Standardization Of Methods To Asses These Properties (Pmqwp#212
- 29 Nov 2021
- Eo14042 Broad Agency Announcement (Baa)Contract -- Assessment Of Smoking And Vaping Risk Of Opioids And Commercial Products, And Standardization Of Methods To Asses These Properties (Pmqwp#212
- Fda Office Of Acq Grant Svcs
- Department Of Health And Human Services (Hhs)
- $760,361.01
- Department Of Health And Human Services (Hhs)